Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 51, pseudogene (RNU1-51P)
- Target
- RNU1-51P
- Molecular classification
- Other (pseudogene, non-coding RNA family, U1 small nuclear RNA pseudogene)
01
Overview
RNU1-51P (RNA, U1 small nuclear 51, pseudogene) is a non-functional genomic element classified as a pseudogene and annotated in human genomic databases. It shares sequence similarity with active U1 small nuclear RNA (snRNA) genes, which are essential components of the spliceosome complex and involved in pre-mRNA splicing. Unlike its functional counterparts, RNU1-51P does not produce a functional RNA and is not known to participate in splicing or any other biological processes. There are no known associations with disease, no therapeutically relevant properties, and no interactions with drugs or diagnostic utility. RNU1-51P is not a therapeutic target, is not implicated in disease, and has no established biological role. Its annotation as a pseudogene means it is a genomic relic with sequence similarity to active U1 snRNA genes but lacking function.
- Other names
- RNU1-51P
02
Mechanism of action
None (as it is not a therapeutic target)
03
Biological functions
None (the gene is a pseudogene; functional U1 snRNAs are involved in pre-mRNA splicing, but pseudogenes like RNU1-51P typically lack biological function)
04
Disease associations
None (there are no known disease associations for this pseudogene)
05
Safety considerations
None specific (since it is not involved in therapy or disease and not targeted by drugs)
06
Interacting drugs
None (there are no known drugs targeting this pseudogene, nor is it a candidate for drug interaction)
07
Biomarkers
None (this pseudogene is not used as a clinical biomarker)
Beyond the preview
Go deeper on RNA, U1 small nuclear 51, pseudogene (RNU1-51P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U1 small nuclear 51, pseudogene (RNU1-51P).